SE8902607D0 - Oxaza heterocycles and pharmaceutical compositions containing same - Google Patents

Oxaza heterocycles and pharmaceutical compositions containing same

Info

Publication number
SE8902607D0
SE8902607D0 SE8902607A SE8902607A SE8902607D0 SE 8902607 D0 SE8902607 D0 SE 8902607D0 SE 8902607 A SE8902607 A SE 8902607A SE 8902607 A SE8902607 A SE 8902607A SE 8902607 D0 SE8902607 D0 SE 8902607D0
Authority
SE
Sweden
Prior art keywords
heterocycles
oxaza
agents
pharmaceutical compositions
compositions containing
Prior art date
Application number
SE8902607A
Other languages
English (en)
Other versions
SE8902607L (sv
SE504933C2 (sv
Inventor
S J Lee
Original Assignee
Biofor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofor Ltd filed Critical Biofor Ltd
Publication of SE8902607D0 publication Critical patent/SE8902607D0/sv
Publication of SE8902607L publication Critical patent/SE8902607L/sv
Publication of SE504933C2 publication Critical patent/SE504933C2/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/021,2-Oxazines; Hydrogenated 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/04Seven-membered rings having the hetero atoms in positions 1 and 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE8902607A 1988-08-01 1989-07-27 Oxazaheterocykler och deras mellanprodukter samt farmaceutiska kompositioner innehållande sagda oxazaheterocykler SE504933C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/227,572 US4892870A (en) 1988-08-01 1988-08-01 Oxaza heterocycles and pharmaceutical compositions containing same

Publications (3)

Publication Number Publication Date
SE8902607D0 true SE8902607D0 (sv) 1989-07-27
SE8902607L SE8902607L (sv) 1990-02-26
SE504933C2 SE504933C2 (sv) 1997-05-26

Family

ID=22853624

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8902607A SE504933C2 (sv) 1988-08-01 1989-07-27 Oxazaheterocykler och deras mellanprodukter samt farmaceutiska kompositioner innehållande sagda oxazaheterocykler

Country Status (9)

Country Link
US (1) US4892870A (sv)
JP (1) JPH0278671A (sv)
AU (1) AU3893389A (sv)
BE (1) BE1002955A4 (sv)
CA (1) CA1324130C (sv)
DE (1) DE3925477A1 (sv)
FR (1) FR2634764B1 (sv)
GB (1) GB2221464B (sv)
SE (1) SE504933C2 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW204339B (sv) * 1990-05-17 1993-04-21 Ciba Geigy Ag
EP0559742A1 (en) * 1990-11-26 1993-09-15 E.I. Du Pont De Nemours And Company Herbicidal oxazine ethers
US5128330A (en) * 1991-02-19 1992-07-07 Biofor, Ltd. Oxazinone substituted phosphines
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
US5215986A (en) * 1992-06-01 1993-06-01 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene oxaza heterocycles
JP3507124B2 (ja) * 1993-05-26 2004-03-15 塩野義製薬株式会社 ベンジリデン誘導体の製造法
ES2118557T3 (es) * 1994-03-09 1998-09-16 Pfizer Compuestos de isoxazolina como inhibidores de la liberacion de tnf.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552585A (en) * 1984-10-04 1985-11-12 Fmc Corporation Herbicidal 2-(aminophenyl)methyl derivatives of 3-isoxazolidinones or 3-oxazinones

Also Published As

Publication number Publication date
SE8902607L (sv) 1990-02-26
GB2221464B (en) 1992-07-08
GB8917527D0 (en) 1989-09-13
GB2221464A (en) 1990-02-07
FR2634764A1 (fr) 1990-02-02
US4892870A (en) 1990-01-09
BE1002955A4 (fr) 1991-10-01
SE504933C2 (sv) 1997-05-26
FR2634764B1 (fr) 1994-01-14
JPH0278671A (ja) 1990-03-19
CA1324130C (en) 1993-11-09
DE3925477A1 (de) 1990-02-08
AU3893389A (en) 1990-02-01

Similar Documents

Publication Publication Date Title
ATE122033T1 (de) Cyancrotonsäureamidverbindung als arzneimittel mit immunmodulierenden eigenschaften.
ES2042520T3 (es) Composiciones farmaceuticas que contienen el ester metilico de levodopa, preparacion y aplicaciones terapeuticas del mismo.
NZ229832A (en) Condensed heterocyclic compounds, preparation and pharmaceutical compositions thereof
ATE146970T1 (de) Behandlung von entzündungen
BR1100089A (pt) Novas sulfonilaminopirimidinas, sua preparação e emprego como medicamento
SE8701348D0 (sv) Improvements in pharmaceutically acceptable salts
DE3768419D1 (de) Pharmazeutische zusammensetzungen mit antineoplastischer wirkung.
ATE38991T1 (de) In 2-stellung substituierte 1,3propyledendephosphonat-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
ATE162181T1 (de) Phenylalkan(en)-säuren mit leukotriene b4 antagonistischer wirkung
SE8902607D0 (sv) Oxaza heterocycles and pharmaceutical compositions containing same
MA19882A1 (fr) Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces acides.
PT100329A (pt) Composicoes a base de di-hidro-4-(3,5-di-terc-butil-4-hidroxi-benzilideno)-metil-2h-1,2-oxazin-3(4h)-ona sob forma micronizada
DK561089A (da) Anvendelse af lactamimider til fremstilling af laegemidler
IT1106299B (it) 5-imminodaunomicina e suoi derivati procedimento per prepararla nonch' composizioni farmaceutiche che la contengono
IL103040A0 (en) Heterocyclically substituted quinolylmethoxy-phenylacetamides,their preparation and pharmaceutical compositions containing them
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
DE3785288D1 (de) Polyarylthioetherzusammensetzung und formkoerper daraus.
IT7819638A0 (it) Vite autofilettante nonche'procedimento per la sua fabbricazione e ganascia di cilindratura per l'attuazione del procedimento.
FI851365L (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
IT7824578A0 (it) Composizione farmaceutica per la terapia di stati di frigidita' ed impotenza.
DE3762854D1 (de) Pharmazeutische zusammensetzungen mit inhalt von 5-phenyl-1,3-dioxoalkenylverbindungen.
MX12192A (es) Composicion farmaceutica para reducir o impedir las arritmias
LV10289A (lv) Jauns pentapeptids ta iegusanas panemiens kompozicija sunu augsanas inhibesanai inhibesanas panemiens
SE8902608L (sv) Pyrrolidin- och piperidonfoereningar och farmaceutiska kompositioner innehaallande dessa

Legal Events

Date Code Title Description
NUG Patent has lapsed